Duke Research Leads to Treatment for Pompe Disease
Pompe disease is a rare genetic disease that can affect multiple organ systems. It requires a team approach to care in order to prevent the many complications that can arise. In addition to genetic specialists, our team includes experts in cardiology, pulmonology, gastroenterology, and nutrition. Our patients also receive care from physical and occupational therapists, as well as speech pathologists.
While there is no cure for Pompe disease, enzyme replacement therapy can reduce or slow the progression of the disease. This lifesaving therapy was developed at Duke following clinical trials that allowed children with Pompe disease to access the therapy before it was widely available. Enzyme replacement therapy has made it possible for people diagnosed with the disease to live longer, fuller lives.
We continue to actively research new and better ways to diagnose Pompe disease early, so children can begin life-changing treatment sooner. We also coordinate clinical trials and research initiatives to establish new treatments and therapies. Children and adults with Pompe disease may be eligible to participate in clinical trials.